Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Sopharma Trading ADXBUL:SFT 82 Dividend Payout Ratio is 0.00 as of Mar. 2026. GuruFocus rates XBUL:SFT with a GF Score™ of 82/100 and a GF Value™ of €7.67 (Significantly Undervalued). The stock has 2 warning signs investors should review. Among 62 Medical Distribution companies, Sopharma Trading AD ranks worse than 1612901.61% on this metric.
The Dividend Payout Ratio is the measure of dividends paid out to shareholders relative to the company's net income. It is calculated as the Dividends per Share divided by the Earnings per Share (Diluted) during the same time period. Sopharma Trading AD's Dividend Payout Ratio for the
months ended in Mar. 2026 was 0.00.
The historical rank and industry rank for Sopharma Trading AD's Dividend Payout Ratio or its related term are showing as below:
During the past 13 years, the highest Dividend Payout Ratio of Sopharma Trading AD was 1.21. The lowest was 0.87. And the median was 1.02.
XBUL:SFT's Dividend Payout Ratio is not ranked *
in the Medical Distribution industry.
Industry Median: 0.43 * Ranked among companies with meaningful Dividend Payout Ratio only.
During the past 13 years, the highest 3-Year average Dividends Per Share Growth Rate of Sopharma Trading AD was 26.00% per year. The lowest was 0.00% per year. And the median was 9.40% per year.
The growth rate is calculated with least square regression.
For more information regarding to dividend, please check our Dividend Page.
* Please note that "special dividend" is not included in the calculation of dividend per share and related fields.
Sopharma Trading AD (XBUL:SFT) Dividend Payout Ratio Explanation
In dividends investing, Dividend Payout Ratio and Dividend Growth Rate are the two most important variables for consideration. A lower payout ratio may indicate that the company has more room to increase its dividends.
Sopharma Trading AD Dividend Payout Ratio Related Terms
Sopharma Trading AD Dividend Payout Ratio Historical Data
* Premium members only.
The historical data trend for Sopharma Trading AD's Dividend Payout Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
XBUL:SFT vs MCK, CAH, COR: Dividend Payout Ratio Comparison
For the Medical Distribution subindustry, Sopharma Trading AD's Dividend Payout Ratio, along with its competitors' market caps and Dividend Payout Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Sopharma Trading AD Dividend Payout Ratio vs Medical Distribution Industry
For the Medical Distribution industry and Healthcare sector, Sopharma Trading AD's Dividend Payout Ratio distribution charts can be found below:
* The bar in red indicates where Sopharma Trading AD's Dividend Payout Ratio falls into.
Sopharma Trading AD Dividend Payout Ratio Calculation
The Dividend Payout Ratio is the measure of dividends paid out to shareholders relative to the company's net income. It is calculated as the Dividends per Share divided by the Earnings per Share (Diluted) during the same time period.
Sopharma Trading AD's Dividend Payout Ratio for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Sopharma Trading AD (XBUL:SFT) has a Dividend Payout Ratio of 0.00 as of Mar. 2026. Dividend payout ratio is the percent of company earnings paid out as dividends. View historical data on Sopharma Trading AD and its competitors. Over the past decade, Sopharma Trading AD's Dividend Payout Ratio has ranged from 0.87 to 1.21. According to the industry distribution chart, Sopharma Trading AD ranks #999999 out of 62 companies in the Medical Distribution industry.
Is Sopharma Trading AD's Dividend Payout Ratio too high?
Sopharma Trading AD's current Dividend Payout Ratio is 0.00. Over the past 10 years, this metric has ranged from a low of 0.87 to a high of 1.21. Based on the distribution chart, Sopharma Trading AD ranks #999999 out of 62 companies in the Medical Distribution industry, which is in the bottom quartile relative to peers. Overall, Sopharma Trading AD has a GF Score™ of 82/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Sopharma Trading AD's Dividend Payout Ratio compare to MCK and CAH?
According to the Medical Distribution industry distribution chart, Sopharma Trading AD ranks #999999 out of 62 companies for Dividend Payout Ratio. This places Sopharma Trading AD in the lower half of its industry. The industry median Dividend Payout Ratio is 0.43. Historically, Sopharma Trading AD's own Dividend Payout Ratio has ranged from 0.87 to 1.21 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Dividend Payout Ratio for a Medical Distribution company?
The median Dividend Payout Ratio among Medical Distribution companies is 0.43, based on 62 companies in the industry. Companies in the top quartile (top 25%) have a Dividend Payout Ratio significantly above this median, while those in the bottom quartile fall well below. However, Dividend Payout Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Dividend Payout Ratio mean?
A high Dividend Payout Ratio can signal that a stock is expensive relative to its fundamentals. Dividend payout ratio is the percent of company earnings paid out as dividends. View historical data on Sopharma Trading AD and its competitors. For the Medical Distribution industry, the median Dividend Payout Ratio is 0.43 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Sopharma Trading AD's current Dividend Payout Ratio is 0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Sopharma Trading AD stock overvalued right now?
Based on GuruFocus' analysis, Sopharma Trading AD (XBUL:SFT) is currently considered Significantly Undervalued. The stock's GF Value™ is €7.67, compared to a current price of €2.86 — trading 62.7% below its estimated fair value. The current Dividend Payout Ratio is 0.00. Sopharma Trading AD's overall GF Score™ is 82/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Dividend Payout Ratio calculated?
Dividend Payout Ratio is calculated from a company's financial statements. For Sopharma Trading AD (XBUL:SFT), the current Dividend Payout Ratio is 0.00 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Sopharma Trading AD (XBUL:SFT) Overvalued in 2026?
Based on GuruFocus' analysis, Sopharma Trading AD stock appears to be undervalued.
The current stock price of €2.86 is trading 62.7% below its estimated GF Value™ of €7.67.
GuruFocus considers Sopharma Trading AD to be Significantly Undervalued.
Key valuation signals for XBUL:SFT:
Dividend Payout Ratio: 0.00
GF Value™: €7.67 vs. price of €2.86 (62.7% below fair value)
No single metric tells the full story. See the XBUL:SFT stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Sopharma Trading AD is a Bulgaria based company operating in the pharmaceutical sector. The company is engaged in the distribution of pharmaceutical items, including a portfolio of international brands, medicinal products, medical supplies, sanitary and hygienic materials, vitamins, nutritional supplements, cosmetics, medical equipment, and equipment. It also provides turnkey solutions for the construction of medical and hospital establishments. In addition, the group also caters logistics solutions for import, storage, and distribution of goods to end customers.
82GF Score
Get the complete analysis for XBUL:SFT
Dividend Payout Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
XBUL:SFT has been successfully added to your 
